SecBot SecBot

GLAXF

GSK plc
OTC· Pharmaceutical Preparations· Inc. X0· CIK 0001131399 Biotech & Drug Discovery
$26.12 +1.22 (+4.90%)
Oct 26 4:00 PM ET · prev $24.90
1 year
+24.6%
from $20.97 · Oct 27
30 days
+8.8%
from $24.00
52-week range
$20.97–31.48
−17% from high · low Oct 27
Avg volume 20D
1.1K
Oct 6 spike 13.4K
Short interest
🔒 Subscribers only
Filing reports
51
analyzed by SecBot
SecBot read BULLISH 5 reports · latest
Balance 0 bearish · 1 bullish · 4 neutral oldest → newest, height = score
Avg score ·High conf. 5/5
Strongest BULLISH GSK plc announced a definitive agreement to acquire Nuvalent, Inc. for $10.6 billion ($124/share in cash), a…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • TrendUPTREND

    6% above its 50-day average.

Who's buying

13F
Top holderSharesValue
Aristotle Capital Management, LLC2,633,914$69.3M

Quarterly 13F filings are due 45 days after each quarter ends.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Jun 10, 2026 SEC
GSK filed a Form 6-K reporting a routine transaction by Maya Martinez-Davis, President US, who acquired 9.4289…
6-K — Impact 1/10
Jun 9, 2026 SEC
GSK plc filed a 6-K disclosing that Non-Executive Director Dr. Hal Barron was appointed as an Independent Director and…
6-K — Impact 1/10
Jun 9, 2026 SEC
GSK plc announced a definitive agreement to acquire Nuvalent, Inc. for $10.6 billion ($124/share in cash), a 40%…
6-K — Impact 7/10

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short

SecBot reports

51 filings · 13 bullish · 0 bearish · 38 neutral
All GLAXF filing & press-release reports (51)